Arrowstreet Capital’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,756
| Closed | -$312K | – | 1898 |
|
|
2024
Q4 | $312K | Buy |
13,756
+913
| +7% | +$20.7K | ﹤0.01% | 1617 |
|
|
2024
Q3 | $233K | Buy |
+12,843
| New | +$233K | ﹤0.01% | 1634 |
|
|
2024
Q2 | – | Sell |
-266,074
| Closed | -$9.43M | – | 1642 |
|
|
2024
Q1 | $9.43M | Sell |
266,074
-193,388
| -42% | -$6.86M | 0.01% | 700 |
|
|
2023
Q4 | $20M | Sell |
459,462
-68,708
| -13% | -$2.99M | 0.02% | 420 |
|
|
2023
Q3 | $20.2M | Sell |
528,170
-53,709
| -9% | -$2.05M | 0.02% | 388 |
|
|
2023
Q2 | $23.9M | Sell |
581,879
-88,084
| -13% | -$3.62M | 0.03% | 362 |
|
|
2023
Q1 | $38.5M | Sell |
669,963
-95
| -0% | -$5.45K | 0.05% | 310 |
|
|
2022
Q4 | $37.6M | Buy |
670,058
+17,677
| +3% | +$991K | 0.05% | 284 |
|
|
2022
Q3 | $27.6M | Buy |
652,381
+137,931
| +27% | +$5.84M | 0.04% | 323 |
|
|
2022
Q2 | $27.8M | Buy |
514,450
+280,004
| +119% | +$15.1M | 0.04% | 318 |
|
|
2022
Q1 | $15.1M | Buy |
234,446
+170,543
| +267% | +$11M | 0.02% | 456 |
|
|
2021
Q4 | $4.28M | Sell |
63,903
-118,121
| -65% | -$7.91M | 0.01% | 851 |
|
|
2021
Q3 | $12.5M | Buy |
182,024
+13,360
| +8% | +$915K | 0.02% | 664 |
|
|
2021
Q2 | $11.5M | Buy |
+168,664
| New | +$11.5M | 0.01% | 798 |
|
|
2020
Q2 | – | Sell |
-53,700
| Closed | -$2.4M | – | 2370 |
|
|
2020
Q1 | $2.4M | Buy |
53,700
+42,100
| +363% | +$1.88M | 0.01% | 998 |
|
|
2019
Q4 | $676K | Buy |
+11,600
| New | +$676K | ﹤0.01% | 1428 |
|
|
2017
Q2 | – | Sell |
-154,800
| Closed | -$6.52M | – | 1183 |
|
|
2017
Q1 | $6.52M | Buy |
+154,800
| New | +$6.52M | 0.02% | 495 |
|
|
2016
Q4 | – | Sell |
-348,646
| Closed | -$14.4M | – | 2052 |
|
|
2016
Q3 | $14.4M | Buy |
348,646
+237,668
| +214% | +$9.81M | 0.05% | 362 |
|
|
2016
Q2 | $4.43M | Buy |
+110,978
| New | +$4.43M | 0.01% | 616 |
|
|
2016
Q1 | – | Sell |
-6,000
| Closed | -$203K | – | 1418 |
|
|
2015
Q4 | $203K | Buy |
+6,000
| New | +$203K | ﹤0.01% | 1311 |
|